Verana Health, a life sciences product development platform spun out from Stanford and formerly known as DigiSight, has received funding from GV and GE Ventures.
Verana Health, a US-based creator of a life science product development platform spun out from Stanford University, has raised $30m in a series C round led by GV, the corporate venturing subsidiary of conglomerate Alphabet
GE Ventures, the corporate venture capital vehicle for industrial product maker General Electric, also took part in the round, along with investment firm Lagunita Biosciences, VC firm Biomatics Capital and private investor Brook Byers.
Verana has built a platform that utilises regulatory-grade datasets from the…